Emily L. Yao

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Unlocking the potential of agonist antibodies for treating cancer using antibody engineering”.

Unlocking the potential of agonist antibodies for treating cancer using antibody engineering

Trends in Molecular Medicine(2022)10.1016/j.molmed.2022.09.012

N/A

0DataRank · unranked

25 citations

Timon S. Lwo, Emily L. Yao, Peter M. Tessier, Harkamal S. Jhajj

Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.11.571146

N/A

0DataRank · unranked

0 citations

John S. Schardt, Namir Khalasawi, Emily L. Yao, Timon S. Lwo, Na-Young Kwon +4 more

Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors

Cell chemical biology(2024)10.1016/j.chembiol.2024.03.010

N/A

0DataRank · unranked

5 citations

John S. Schardt, Namir Khalasawi, Emily L. Yao, Timon S. Lwo, Na-Young Kwon +4 more